Status:
COMPLETED
Assessing Prevalence Of Beta Lactamase Production From Clinical Isolates Of Hospitalized Patients And Comparison Of Antibiotic Susceptibility Patterns
Lead Sponsor:
Pfizer
Conditions:
Infection
Eligibility:
All Genders
Brief Summary
EGAST 2008 is a prospective, non interventional, multicentric study (approximately 2000 isolates from 15- 20 sites). Objectives: * Comparison of antimicrobial susceptibility using disc-diffusion met...
Detailed Description
n/a n/a
Eligibility Criteria
Inclusion
- Isolates (as specified in the observational plan) from hospitalised patients
Exclusion
- Isolates obtained from outpatients will not be included for the study. Isolates from repeat cultures performed during in-patient follow-up that were previously recruited into the study will be excluded.
- Isolates identified as commensals or contaminants will be excluded
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
2039 Patients enrolled
Trial Details
Trial ID
NCT00728624
Start Date
November 1 2008
End Date
September 1 2009
Last Update
March 10 2017
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Hyderabad, Andhra Pradesh, India, 500 082
2
Pfizer Investigational Site
Bangalore, Karnataka, India, 560 076
3
Pfizer Investigational Site
Bangalore, Karnataka, India, 560034
4
Pfizer Investigational Site
Manipal, Karnataka, India, 576 104